Multi-Center, Non-Interventional Extension Study of the Safety and Efficacy of CLS-TA for the Treatment of Macular Edema Associated With Non-Infectious Uveitis
Phase of Trial: Phase III
Latest Information Update: 12 Oct 2017
At a glance
- Drugs Triamcinolone (Primary)
- Indications Panuveitis; Uveitis
- Focus Therapeutic Use
- Acronyms MAGNOLIA
- Sponsors Clearside Biomedical
- 09 Oct 2017 Planned End Date changed from 1 Sep 2017 to 1 Aug 2018.
- 09 Oct 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Aug 2018.
- 22 Dec 2016 Status changed from not yet recruiting to recruiting.